Диссертация (1140954), страница 15
Текст из файла (страница 15)
– 2006. – V. 4. – P. 437–447.135. Mishra P. Chemokines at the crossroads of tumor-fibroblast interactions thatpromote malignancy / P. Mishra, D. Banerjee, A. Ben-Baruch // J Leukoc Biol. –2011. – V. 89. – P. 31–39.136. Moazzeni S.M. Synergistic effect of Toll-like receptor 4 and 7/8 agonists isnecessary to generate potent blast-derived dendritic cells in acute myeloidleukemia / S.M.
Moazzeni, J. Hadjati // Leuk Res. – 2012. – V. 36(9). – P. 1193–1199137. Möhle R. The chemokine receptor CXCR-4 is expressed on CD34+hematopoietic progenitors and leukemic cells and mediates transendothelialmigration induced by stromal cell-derived factor-1 / R. Möhle, F. Bautz, S. Rafii,M.A. Moore, W. Brugger, L. Kanz // Blood. – 1998.
– V. 91(12). – P. 45234530.138. Monteagudo C. CXCR3 chemokine receptor immunoreactivity in primarycutaneous malignant melanoma: correlation with clinicopathological prognosticfactors / C. Monteagudo, J.M. Martin, E. Jorda, A. Llombart-Bosch // J. Clin.Pathol. – 2007. – V. 60(6). – P. 596–599.139. Müller A.
Involvement of chemokine receptors in breast cancer metastasis / A.Müller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan et al. // Nature. –2001. – V. 410. – P. 50–56.140. Muller A. Chemokine receptors in head and neck cancer: association withmetastatic spread and regulation during chemotherapy / A. Muller, E. Sonkoly, C.Eulert, P.A. Gerber, R. Kubitza et al. // Int. J. Cancer. – 2006. – V.
118(9) – P.2147–2157.97141. Murakami T. Expression of CXC chemokine receptor-4 enhances the pulmonarymetastatic potential of murine B16 melanoma cells / T. Murakami, W. Maki, A.R.Cardones, H. Fang, A. Tun Kyi et al. // Cancer Res. – 2002. – V. 62(24). – P.7328–7334.142. Murakami T. The role of CXCR3 and CXCR4 in colorectal cancer metastasis / T.Murakami, K. Kawada, M.
Iwamoto, M. Akagami, K. Hida et al. // Int. J. Cancer.– 2013. – V. 132(2). – P. 276–287.143. Naik E. Mitochondrial reactive oxygen species drive proinflammatory cytokineproduction / E. Naik, V.M. Dixit // J Exp Med. – 2011. – V. 208. – P. 417–420.144. Naugler W.E. Gender disparity in liver cancer due to sex differences in MyD88dependent IL-6 production / W.E. Naugler et al. // Science.
– 2007. – V. 317. – P.121–124.145. Ngo V.N. Oncogenically active MYD88 mutations in human lymphoma / V.N.Ngo et al. // Nature. – 2011. – V. 470. – P. 115–119.146. Nguyen D.X. Metastasis: from dissemination to organ-specific colonization /D.X. Nguyen, P.D. Bos, J. Massagué // Nat Rev Cancer. – 2009. – V. 9. – P. 274–84.147. Nourizadeh M. In vitro induction of potent tumor-specific cytotoxic Tlymphocytes using TLR agonistactivated AML-DC / M.
Nourizadeh, F.Masoumi, A. Memarian, K. Alimoghaddam, S.M. Moazzeni et al. // TargetOncol. – 2014. – V. 9(3). – P. 225–237.148. Ochi A. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice andhumans / A. Ochi et al. // J Clin Invest. – 2012. – V. 122. – P. 4118–4129.149. Ochi A. MyD88 inhibition amplifies dendritic cell capacity to promote pancreaticcarcinogenesis via Th2 cells / A. Ochi et al.
// J Exp Med. – 2012. – V. 209. – P.1671–1687.150. Oda Y. CXCR4 and VEGF expression in the primary site and the metastatic siteof human osteosarcoma: analysis within a group of patients, all of whom98developed lung metastasis / Y. Oda, H. Yamamoto, S. Tamiya, S. Matsuda, K.Tanaka et al. // Mod. Pathol. – 2006. – V. 19(5). – P. 738–745.151. Oliveira J.G.
Profiles of Gene Polymorphisms in Cytokines and Toll-LikeReceptors with Higher Risk for Gastric Cancer / J.G. Oliveira, A.F. Rossi, D.M.Nizato, K Miyasaki, A.E. Silva // Dig Dis Sci. – 2013152. Okada T. Chemokine requirements for B cell entry to lymph nodes and Peyer'spatches / T. Okada, V.N. Ngo, E.H. Ekland, R. Forster, M.
Lipp et al. // J. Exp.Med. – 2002. – V. 196(1). – P. 65–75.153. Olkhanud P.B. Breast cancer lung metastasis requires expression of chemokinereceptor CCR4 and regulatory T cells / P.B. Olkhanud, D. Baatar, M. Bodogai, F.Hakim, R. Gress et al. // Cancer Res. – 2009. – V. 69. – P. 5996–6004.154. Owen J.D. Enhanced tumor-forming capacity for immortalized melanocytesexpressing melanoma growth stimulatory activity/growth-regulated cytokine betaand gamma proteins / J.D.
Owen, R. Strieter, M. Burdick, H. Haghnegahdar, L.Nanney et al. // Int. J. Cancer. – 1997. – V. 73(1). – P. 94–103.155. Pandey S. Impact of Toll-like receptors [TLR] 2 (−196 to −174 del) and TLR 4(Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women /S. Pandey et al. // Gynecologic oncology. – 2009. – V. 114. – P. 501–505.156. Park E.J. Dietary and genetic obesity promote liver inflammation andtumorigenesis by enhancing IL-6 and TNF expression / E.J. Park et al. // Cell.
–2010. – V. 140. – P. 197–208.157. Parkin D.M. The global health burden of infection-associated cancers in the year2002 / D.M. Parkin // Int J Cancer. – 2006. – V. 118. – P. 3030–3044.158. Payne A.S. The role of chemokines in melanoma tumor growth and metastasis /A.S. Payne, L.A. Cornelius // J Invest Dermatol. – 2002. – V. 118(6). – P.
915922.159. Peng G. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cellfunction / G. Peng et al. // Science. – 2005. – V. 309. – P. 1380–1384.99160. Peng W. PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γinducible chemokines / W. Peng, C. Liu, C. Xu, Y. Lou, J. Chen et al. // CancerRes. – 2012. – V. 72. – P. 5209–5218.161. Phillips R.J.
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4biological axis in non-small cell lung cancer metastases / R.J. Phillips, M.D.Burdick, M. Lutz, J.A. Belperio, M.P. Keane, R.M. Strieter // Am. J. Respir. Crit.Care Med. – 2003. – V. 167(12). – P. 1676–1686.162. Popivanova B.K. Blocking TNF-alpha in mice reduces colorectal carcinogenesisassociated with chronic colitis / B.K. Popivanova et al.
// J Clin Invest. – 2008. –V. 118. – P. 560–570.163. Pradelli E. Antagonism of chemokine receptor CXCR3 inhibits osteosarcomametastasis to lungs / E. Pradelli, B. Karimdjee-Soilihi, J.F. Michiels, J.E. Ricci,M.A. Millet et al. // Int. J. Cancer. – 2009. – V. 125(11). – P. 2586–2594.164. Rakoff-Nahoum S. Regulation of spontaneous intestinal tumorigenesis throughthe adaptor protein MyD88 / S.
Rakoff-Nahoum, R. Medzhitov // Science. –2007. – V. 317. – P. 124–127.165. Reddy B.S. Effect of intestinal microflora on 2,2′-dimethyl-4-aminobiphenylinduced carcinogenesis in F344 rats / B.S. Reddy, K. Watanabe // J Natl CancerInst. – 1978. – V. 61. – P. 1269–1271.166. Ren T. Functional expression of TLR9 is associated to the metastatic potential ofhuman lung cancer cell: functional active role of TLR9 on tumor metastasis / T.Ren et al. // Cancer biology & therapy.
– 2007. – V. 6. – P. 1704–1709.167. Rhee S.H. Toll-like receptor 5 engagement modulates tumor development andgrowth in a mouse xenograft model of human colon cancer / S.H. Rhee, E. Im, C.Pothoulakis // Gastroenterology. – 2008. – V. 135. – P. 518–528.168. Rhyasen G.W. Differential IRAK signaling in hematologic malignancies / G.W.Rhyasen, L. Bolanos, D.T.
Starczynowski // Exp Hematol. – 2013. – V. 41(12). –P. 1005–1007.100169. Rigo A. Macrophages may promote cancer growth via a GM-CSF/HB-EGFparacrine loop that is enhanced by CXCL12 / A. Rigo, M. Gottardi, A. Zamò, P.Mauri, M. Bonifacio, M. Krampera et al. // Mol Cancer. – 2010. – V. 9. – P. 273.170. Russell H.V. CXCR4 expression in neuroblastoma primary tumors is associatedwith clinical presentation of bone and bone marrow metastases / H.V. Russell, J.Hicks, M.F. Okcu, J.G.
Nuchtern // J. Pediatr. Surg. – 2004. – V. 39(10). – P.1506–1511.171. Sakurai T. Hepatocyte Necrosis Induced by Oxidative Stress and IL-1alphaRelease Mediate Carcinogen-Induced Compensatory Proliferation and LiverTumorigenesis / T. Sakurai et al. // Cancer Cell. – 2008. – V. 14. – P. 156–165.172. Salcedo R. Role of chemokines in angiogenesis: CXCL12/SDF - 1 and CXCR4interaction, a key regulator of endothelial cell responses / R. Salcedo, J.J.Oppenheim // Microcirculation. – 2003. – V.
10. – P. 359–370.173. Savarin-Vuaillat C. Chemokines and chemokine receptors in neurologicaldisease: raise, retain, or reduce? / C. Savarin-Vuaillat, R.M. Ransohoff //Neurotherapeutics. – 2007. – V. 4(4). – P. 590–601.174. Scala S. Human melanoma metastases express functional CXCR4 / S.
Scala, P.Giuliano, P.A. Ascierto, C. Ierano, R. Franco et al. // Clin. Cancer Res. – 2006. –V. 12(8). – P. 2427–2433.175. Schimanski C.C. Effect of chemokine receptors CXCR4 and CCR7 on themetastatic behavior of human colorectal cancer / C.C. Schimanski, S. Schwald, N.Simiantonaki, C. Jayasinghe, U. Gönner, V. Wilsberg et al. // Clin Cancer Res. –2005. – V.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
